RESEARCH
27 Feb 2026
MARKET TRENDS
19 Feb 2026
RESEARCH
13 Feb 2026
INNOVATION
11 Feb 2026

INVESTMENT
9 Feb 2026
Milestone-based deal with lambic reflects cautious bet on artificial intelligence in pharma research

RESEARCH
27 Feb 2026
Valinor and Renew join forces to build a vast AI-ready neurology dataset, hoping to sharpen drug discovery for Alzheimer’s, Parkinson’s, a...

MARKET TRENDS
19 Feb 2026
AI-powered multi-omics is reshaping drug discovery, but business models and market claims demand a closer look

RESEARCH
13 Feb 2026
Athos and Xeptiva use AI-powered multi-omics to sharpen drug discovery and reduce costly development risks

INNOVATION
11 Feb 2026
BioNeMo links AI models with lab testing, aiming to speed drug research and cut costs through closer industry collaboration

INVESTMENT
9 Feb 2026
Milestone-based deal with lambic reflects cautious bet on artificial intelligence in pharma research

MARKET TRENDS
5 Feb 2026
Drugmakers race to lock in AI partners, cut risk, and secure a lead in data-driven discovery
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.